2024. Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s334. DOI:https://doi.org/10.25251/skin.8.supp.334.